ATE529131T1 - Impfung mittels gezielter transkutaner freisetzung - Google Patents

Impfung mittels gezielter transkutaner freisetzung

Info

Publication number
ATE529131T1
ATE529131T1 AT06795406T AT06795406T ATE529131T1 AT E529131 T1 ATE529131 T1 AT E529131T1 AT 06795406 T AT06795406 T AT 06795406T AT 06795406 T AT06795406 T AT 06795406T AT E529131 T1 ATE529131 T1 AT E529131T1
Authority
AT
Austria
Prior art keywords
vaccination
transcutane
targeted
release
antigen
Prior art date
Application number
AT06795406T
Other languages
English (en)
Inventor
Behazine Combadiere
Annika Vogt
Ulrike Blume-Peytavi
Brigitte Autran
Christine Katlama
Hans Schaeffer
Original Assignee
Fond Bettencourt Schueller
Univ Paris Curie
Univ Charite Universitaetsmedizin Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Bettencourt Schueller, Univ Paris Curie, Univ Charite Universitaetsmedizin Berlin filed Critical Fond Bettencourt Schueller
Application granted granted Critical
Publication of ATE529131T1 publication Critical patent/ATE529131T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06795406T 2005-06-23 2006-06-23 Impfung mittels gezielter transkutaner freisetzung ATE529131T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0506412A FR2887457B1 (fr) 2005-06-23 2005-06-23 Vaccination par ciblage transcutane
PCT/IB2006/002417 WO2006136959A1 (en) 2005-06-23 2006-06-23 Vaccination by transcutaneous targeting

Publications (1)

Publication Number Publication Date
ATE529131T1 true ATE529131T1 (de) 2011-11-15

Family

ID=35785884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06795406T ATE529131T1 (de) 2005-06-23 2006-06-23 Impfung mittels gezielter transkutaner freisetzung

Country Status (9)

Country Link
US (1) US8956617B2 (de)
EP (1) EP1898949B1 (de)
JP (1) JP5123849B2 (de)
AT (1) ATE529131T1 (de)
AU (1) AU2006260596B9 (de)
CA (1) CA2612867C (de)
ES (1) ES2378516T3 (de)
FR (1) FR2887457B1 (de)
WO (1) WO2006136959A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082301A1 (en) 2007-12-20 2009-07-02 Telefonaktiebolaget L M Ericsson (Publ) A method and an apparatus for handling multimedia calls
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
JP5588990B2 (ja) * 2008-10-31 2014-09-10 トレムアールエックス， インコーポレイテッド 機械的表皮破壊を介したポックスウイルスベクターによるワクチン接種
EP2609742A4 (de) 2010-08-27 2015-07-08 Univ Leland Stanford Junior Mikroskopie-bildgebungsvorrichtung mit erweiterten abbildungseigenschaften
DE102011018499A1 (de) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut
JP5917626B2 (ja) * 2014-07-28 2016-05-18 トレムアールエックス， インコーポレイテッド 機械的表皮破壊を介したポックスウイルスベクターによるワクチン接種
FR3132146A1 (fr) * 2022-01-27 2023-07-28 Genoskin Modèle humain ex vivo destiné à l’évaluation du potentiel vaccinal d’une composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US5910306A (en) 1996-11-14 1999-06-08 The United States Of America As Represented By The Secretary Of The Army Transdermal delivery system for antigen
ES2228467T3 (es) * 1999-02-03 2005-04-16 Biosante Pharmaceuticals, Inc. Particulas terapeuticas de fosfato calcico y metodos de fabricacion y su uso.
US6436402B1 (en) * 1999-10-15 2002-08-20 Merck & Co., Inc. Process for making human papillomavirus virus-like particles with improved properties
US6358242B1 (en) * 1999-11-12 2002-03-19 Ceramoptec Industries, Inc. Post laser treatment for permanent hair removal
ES2310201T3 (es) * 2001-02-13 2009-01-01 Government Of The United States Of America, As Represented By The Secretary Of The Army Vacuna para inmunizacion transcutanea contra la diarrea de los viajeros.
ATE471990T1 (de) * 2001-08-13 2010-07-15 Univ Rochester Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln
US20030190308A1 (en) * 2002-03-19 2003-10-09 Braun Ralph P. Adjuvant
WO2004012657A2 (en) * 2002-08-01 2004-02-12 Immusonic, Inc. Beta-glucan containing composites, methods for manufacturing and for using such composites
EP1449520A1 (de) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Verwendung von PVP-Jod zur Behandlung von Herpes
CA2517675A1 (en) * 2003-03-26 2004-10-07 Cytos Biotechnology Ag Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
AU2004285484A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery

Also Published As

Publication number Publication date
US20100285099A1 (en) 2010-11-11
EP1898949B1 (de) 2011-10-19
AU2006260596B9 (en) 2012-09-13
CA2612867C (en) 2015-08-11
JP2008543924A (ja) 2008-12-04
AU2006260596B2 (en) 2012-05-10
ES2378516T3 (es) 2012-04-13
US8956617B2 (en) 2015-02-17
FR2887457B1 (fr) 2007-10-05
JP5123849B2 (ja) 2013-01-23
WO2006136959A1 (en) 2006-12-28
AU2006260596A1 (en) 2006-12-28
EP1898949A1 (de) 2008-03-19
CA2612867A1 (en) 2006-12-28
FR2887457A1 (fr) 2006-12-29

Similar Documents

Publication Publication Date Title
ATE529131T1 (de) Impfung mittels gezielter transkutaner freisetzung
CY1121789T1 (el) Νεες ανοσοενισχυτικες συνθεσεις
EA201170493A1 (ru) Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
WO2008060669A3 (en) Vaccine for avian influenza and methods of use
CY1118732T1 (el) Εμβολια κυστιδιων βασει gna1870 για προστασια ευρεως φασματος εναντι νοσων προκαλουμενων απο neisseria meningitidis
ATE426412T1 (de) Adjuvante influenza-vakzine
DK2066344T3 (da) Inaktiveret Poliovirus kombinationsvaccine
TW200806316A (en) Yeast-based vaccine for inducing an immune response
BR112012021805A2 (pt) dispositivo de eletroporação de pele tolerável e minimamente invasivo
ZA200802892B (en) Vaccines and methods to treat canine influenza
CL2009001195A1 (es) Adyuvante inmune que comprende un inhibidor de iap capaz de modular la actividad inmune; composicion farmaceutica y vacuna que lo comprenden; metodo para mejorar una respuesta inmune de un individuo; metodo para tratar un cancer en un individuo; metodo para tratar infeccion; metodo para tratar trastornos autoinmune.
PE20151588A1 (es) Vacuna contra el virus del dengue
BR0316346A (pt) Vacina para vìrus do nilo ocidental
WO2008148057A3 (en) Cationic lipids compositions and methods for enhancing immune responses to vaccines
IN2015MN00038A (de)
WO2011159814A3 (en) Novel live recombinant booster vaccine against tuberculosis
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
BR112015021523A8 (pt) composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
BR112017028212A2 (pt) vacinação concomitante contra dengue e febre amarela
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
DE602006012300D1 (de) Impfstoff gegen burkholderia-infektionen
BR112012009239A2 (pt) ''adjuvante para vacinas,vacina, uso do adjuvante, vetores de expressão eucariótica e células eucarióticas modificadas
MX348137B (es) Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena.
ECSP099066A (es) Vacuna combinada estreptococica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1898949

Country of ref document: EP